Last reviewed · How we verify
Peptide pulsed Dendritic cell — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Peptide pulsed Dendritic cell (Peptide pulsed Dendritic cell) — Universidad Nacional de Colombia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Peptide pulsed Dendritic cell TARGET | Peptide pulsed Dendritic cell | Universidad Nacional de Colombia | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Peptide pulsed Dendritic cell CI watch — RSS
- Peptide pulsed Dendritic cell CI watch — Atom
- Peptide pulsed Dendritic cell CI watch — JSON
- Peptide pulsed Dendritic cell alone — RSS
Cite this brief
Drug Landscape (2026). Peptide pulsed Dendritic cell — Competitive Intelligence Brief. https://druglandscape.com/ci/peptide-pulsed-dendritic-cell. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing